Surveillance of transmitted resistance to antiretroviral drug classes among young children in the western cape province of SOUTH AFRICA

Pediatric Infectious Disease Journal

Volumn 29, Issue 4, 2010, Pages 370-371

  Van Zyl, Gert U ^a   Cotton, Mark F ^b   Claassen, Mathilda ^a   Abrahams, Charmaine ^a   Preiser, Wolfgang ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Children; South Africa; Surveillance; Transmitted antiretroviral drug resistance

Indexed keywords

NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADOLESCENT; ANALYTIC METHOD; ANTIVIRAL RESISTANCE; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG SURVEILLANCE PROGRAM; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INFANT; MUTATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SCHOOL CHILD; SOUTH AFRICA; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION;

EID: 77950263958     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181c4dada     Document Type: Article

References (16)

1. Pillay D. Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe. Antivir Ther. 2004;9:695-702.
2. Chaix ML, Descamps D, Wirden M, et al. Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France. AIDS. 2009;23:717-724.
3. Petroni A, Deluchi G, Pryluka D, et al. Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients. J Acquir Immune Defic Syndr. 2006;42:506-510.
4. Rodrigues R, Scherer LC, Oliveira CM, et al. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. Virus Res. 2006;116:201-207.
5. Myatt M, Bennett DE. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Antivir Ther. 2008;13(suppl 2):37-48.
6. Bennett DE, Camacho RJ, Otelea D, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS ONE. 2009;4:e4724.
7. Church JD, Mwatha A, Bagenda D, et al. In utero HIV infection is associated with an increased risk of nevirapine resistance in Ugandan infants who were exposed to perinatal single dose nevirapine. AIDS Res Hum Retroviruses. 2009;25:673-677.
8. Arrive E, Newell ML, Ekouevi DK, et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007;36: 1009-1021.
9. Persaud D, Palumbo P, Ziemniak C, et al. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis. 2007;195:1402-1410.
10. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233-2244.
11. Hauser A, Mugenyi K, Kabasinguzi R, et al. Detection and quantification of minor human immunodeficiency virus type 1 variants harboring K103N and Y181C resistance mutations in subtype A and D isolates by allele-specific real-time PCR. Antimicrob Agents Chemother. 2009;53:2965-2973.
12. Church JD, Huang W, Parkin N, et al. Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. AIDS Res Hum Retroviruses. 2009;25:657-663.
13. Toni TA, Asahchop EL, Moisi D, et al. Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection. Antimicrob Agents Chemother. 2009;53:1670-1672.
14. Metzner KJ, Giulieri SG, Knoepfel SA, et al. Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and-adherent patients. Clin Infect Dis. 2009;48:239-247.
15. Dorrington R. Western Cape HIV ASSA projection output. 2005. Available at: http://www.capegateway.gov.za/eng/pubs/reports-research/W/142134. Accessed June 23, 2009.
16. Eley B. Addressing the paediatric HIV epidemic: a perspective from the Western Cape Region of South Africa. Trans R Soc Trop Med Hyg. 2006;100:19-23.